Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4782738
Max Phase: Preclinical
Molecular Formula: C15H13FN4OS
Molecular Weight: 316.36
Molecule Type: Unknown
Associated Items:
ID: ALA4782738
Max Phase: Preclinical
Molecular Formula: C15H13FN4OS
Molecular Weight: 316.36
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(NC(=O)Nc1ccc2nnsc2c1)c1cccc(F)c1
Standard InChI: InChI=1S/C15H13FN4OS/c1-9(10-3-2-4-11(16)7-10)17-15(21)18-12-5-6-13-14(8-12)22-20-19-13/h2-9H,1H3,(H2,17,18,21)
Standard InChI Key: QHOWJTHABRGEON-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 316.36 | Molecular Weight (Monoisotopic): 316.0794 | AlogP: 3.71 | #Rotatable Bonds: 3 |
Polar Surface Area: 66.91 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.06 | CX Basic pKa: | CX LogP: 3.46 | CX LogD: 3.46 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.77 | Np Likeness Score: -2.60 |
1. Yang Z,Zhou Y,Zhong L. (2021) Discovery of BAZ1A bromodomain inhibitors with the aid of virtual screening and activity evaluation., 33 [PMID:33333161] [10.1016/j.bmcl.2020.127745] |
Source(1):